Table 1.

Clinical Characteristics of Patient‐Examined Serum CEACAM1 Levels

	HS	CHC	SVR	CHB	NASH
Number of patients	23	27	46	9	19
Sex, male/female	13/10	13/14	26/20	5/4	5/14
Age, years, median (range)	69 (41‐78)	65 (29‐81)	63.5 (25‐74)	51 (31‐78)	65 (30‐80)
AST, IU/L, median (range)	21 (12‐33)	67 (20‐365)*	22 (12‐188)	33 (20‐108)	54 (23‐137)*
ALT, IU/L, median (range)	16 (9‐41)	58 (10‐313)*	20 (6‐214)	32 (14‐199)	72 (18‐181)*
HCV‐RNA, log IU/mL, median (range)	Not tested	6.4 (4.6‐7.4)	Undetected	Not tested	Not tested

^* P < 0.05 versus HS and SVR.

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; HS, healthy subject.